108 related articles for article (PubMed ID: 18415826)
1. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells.
Strandberg K; Palmberg L; Larsson K
J Asthma; 2008 Apr; 45(3):201-3. PubMed ID: 18415826
[TBL] [Abstract][Full Text] [Related]
2. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells.
Strandberg K; Palmberg L; Larsson K
Respir Med; 2007 Jun; 101(6):1132-9. PubMed ID: 17229563
[TBL] [Abstract][Full Text] [Related]
3. Budesonide enhances Toll-like receptor 2 expression in activated bronchial epithelial cells.
von Scheele I; Larsson K; Palmberg L
Inhal Toxicol; 2010 May; 22(6):493-9. PubMed ID: 20388003
[TBL] [Abstract][Full Text] [Related]
4. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
5. Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils.
Strandberg K; Blidberg K; Sahlander K; Palmberg L; Larsson K
Pulm Pharmacol Ther; 2010 Aug; 23(4):316-23. PubMed ID: 20307681
[TBL] [Abstract][Full Text] [Related]
6. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages.
Donnelly LE; Tudhope SJ; Fenwick PS; Barnes PJ
Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor.
Lovén J; Svitacheva N; Jerre A; Miller-Larsson A; Korn SH
Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271
[TBL] [Abstract][Full Text] [Related]
8. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells.
Korn SH; Jerre A; Brattsand R
Eur Respir J; 2001 Jun; 17(6):1070-7. PubMed ID: 11491146
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pyocyanin-potentiated IL-8 release by steroids in bronchial epithelial cells.
Pan NY; Hui WS; Tipoe GL; Taylor GW; Leung RY; Lam WK; Tsang KW; Mak JC
Respir Med; 2006 Sep; 100(9):1614-22. PubMed ID: 16448811
[TBL] [Abstract][Full Text] [Related]
10. Interactive effects of steroids and beta-agonists on accumulation of type 2 T cells.
Loza MJ; Foster S; Peters SP; Penn RB
J Allergy Clin Immunol; 2008 Mar; 121(3):750.e1-5.e3. PubMed ID: 18155275
[TBL] [Abstract][Full Text] [Related]
11. Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium.
Persdotter S; Lindahl M; Malm-Erjefalt M; von Wachenfeldt K; Korn SH; Stevens T; Miller-Larsson A
Int Arch Allergy Immunol; 2007; 143(3):201-10. PubMed ID: 17290146
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
13. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
14. Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol.
Todorova L; Gürcan E; Miller-Larsson A; Westergren-Thorsson G
Am J Respir Cell Mol Biol; 2006 Jan; 34(1):92-100. PubMed ID: 16166747
[TBL] [Abstract][Full Text] [Related]
15. Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells.
Hung CH; Chu YT; Hua YM; Hsu SH; Lin CS; Chang HC; Lee MS; Jong YJ
Eur Respir J; 2008 Jun; 31(6):1313-21. PubMed ID: 18256057
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells.
Chiu JC; Hsu JY; Fu LS; Chu JJ; Chi CS
J Microbiol Immunol Infect; 2007 Oct; 40(5):388-94. PubMed ID: 17932597
[TBL] [Abstract][Full Text] [Related]
18. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Eur Respir J; 2000 Jan; 15(1):68-74. PubMed ID: 10678623
[TBL] [Abstract][Full Text] [Related]
19. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling.
Roth M; Johnson PR; Rüdiger JJ; King GG; Ge Q; Burgess JK; Anderson G; Tamm M; Black JL
Lancet; 2002 Oct; 360(9342):1293-9. PubMed ID: 12414205
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts.
Descalzi D; Folli C; Nicolini G; Riccio AM; Gamalero C; Scordamaglia F; Canonica GW
Allergy; 2008 Apr; 63(4):432-7. PubMed ID: 18076728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
